ZA916420B - 19-nor steroids having a carbonated chain containing an amide function in position 11 beta,their preparation,their use as medicaments and the pharmaceutical compositions containing them - Google Patents

19-nor steroids having a carbonated chain containing an amide function in position 11 beta,their preparation,their use as medicaments and the pharmaceutical compositions containing them

Info

Publication number
ZA916420B
ZA916420B ZA916420A ZA916420A ZA916420B ZA 916420 B ZA916420 B ZA 916420B ZA 916420 A ZA916420 A ZA 916420A ZA 916420 A ZA916420 A ZA 916420A ZA 916420 B ZA916420 B ZA 916420B
Authority
ZA
South Africa
Prior art keywords
hydrogen
preparation
pharmaceutical compositions
steroids
medicaments
Prior art date
Application number
ZA916420A
Inventor
Andre Claussner
Claussner Andre
Francois Nique
Nique Francois
Jean-Georges Teutsch
Teutsch Jean-Georges
Patrick Van De Velde
Van De Velde Patrick
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9010323A external-priority patent/FR2665901B2/en
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA916420B publication Critical patent/ZA916420B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the compounds: <IMAGE> either n = 1, K = oxygen, R17 = hydroxyl, <IMAGE> R'17 = hydrogen, ethynyl, RA = methyl, RA' = isopropyl, butyl, heptafluorobutyl, X = methylene, phenylene or phenyloxy, Y = -(CH2)7; -(CH2)8-; -(CH2)5-C IDENTICAL C-; -(CH2)q-O-CH2-, q = 5 to 7, and -(CH2)5-S-CH2-, or n = 1 or 2, K = oxygen or sulphur, R17 and R'17 = ketone or R17 = hydroxyl or acyloxy and R'17 = hydrogen, alkyl, alkenyl, alkynyl, X = methylene, arylene, CH2-O, arylenoxy or arylenethio, Y = a bond or aliphatic chain optionally interrupted by arylene, oxygen or sulphur, optionally oxidised, and optionally ending with arylene, Z = bond and if Y and Z = bond, X NOTEQUAL CH2 or CH2-O, RA or RA' = hydrogen, alkyl, heterocycle (5 or 6 members) optionally substituted with RA or RA' NOTEQUAL hydrogen, - or n = 2, or K = sulphur, or X = arylenethio, or RA and RA' = heterocycle substituted by aryl or aralkyl, their preparation, their application as medicinal products and pharmaceutical compositions containing them.
ZA916420A 1990-08-14 1991-08-14 19-nor steroids having a carbonated chain containing an amide function in position 11 beta,their preparation,their use as medicaments and the pharmaceutical compositions containing them ZA916420B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9010323A FR2665901B2 (en) 1989-02-24 1990-08-14 NEW 19-NOR STEROUIDES HAVING IN THE 11BETA POSITION A CARBON CHAIN COMPRISING AN AMIDE FUNCTION, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS.

Publications (1)

Publication Number Publication Date
ZA916420B true ZA916420B (en) 1992-10-28

Family

ID=9399655

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA916420A ZA916420B (en) 1990-08-14 1991-08-14 19-nor steroids having a carbonated chain containing an amide function in position 11 beta,their preparation,their use as medicaments and the pharmaceutical compositions containing them

Country Status (15)

Country Link
EP (1) EP0471612B1 (en)
JP (1) JP3073803B2 (en)
KR (1) KR920004408A (en)
AT (1) ATE162797T1 (en)
AU (1) AU644671B2 (en)
CA (1) CA2049102A1 (en)
DE (1) DE69128820T2 (en)
DK (1) DK0471612T3 (en)
ES (1) ES2112268T3 (en)
GR (1) GR3026315T3 (en)
HU (1) HUT59416A (en)
IE (1) IE912863A1 (en)
MX (1) MX9100647A (en)
PT (1) PT98681B (en)
ZA (1) ZA916420B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685332A1 (en) * 1991-12-20 1993-06-25 Roussel Uclaf NOVEL 19-NOR STEROUIDS HAVING IN THE POSITION 11BETA THIOCARBONIC CHAIN, PROCESS FOR PREPARING SAME, AND INTERMEDIATES THEREOF AND APPLICATION THEREOF AS MEDICAMENTS.
JP3398748B2 (en) * 1993-01-21 2003-04-21 メレルダウファーマスーティカルズ インコーポレイテッド Diarylalkylpiperidines useful as multidrug resistant tumor agents
FR2706454B1 (en) * 1993-06-17 1995-09-15 Roussel Uclaf New 19-Nor steroids, preparation process and intermediates, application as medicaments and pharmaceutical compositions containing them.
US5670521A (en) * 1994-08-05 1997-09-23 Merrell Pharmaceuticals Inc. Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives
DE19724187A1 (en) * 1997-06-02 1998-12-03 Schering Ag 11beta-aryl-substituted 14,17-ethanoestratrienes, process for the preparation of these compounds and their use in the manufacture of medicaments
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
AU6228299A (en) * 1998-10-29 2000-05-22 Teikoku Hormone Mfg. Co., Ltd. 2-substituted-d-homooxasteroid derivatives
DE19929715A1 (en) * 1999-06-24 2000-12-28 Schering Ag New 11-beta-long chain substituted estratriene derivatives, are antiestrogens or tissue-selective partial estrogens useful e.g. for treating hormone-dependent cancer or osteoporosis
DE102009034526A1 (en) * 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-ethynylphenyl derivatives, process for their preparation and their use for the treatment of diseases
DE202011111014U1 (en) 2010-11-05 2018-05-02 Senomyx, Inc. Compounds useful as modulators of TRPM8
US10392371B2 (en) 2015-10-01 2019-08-27 Senomyx, Inc. Compounds useful as modulators of TRPM8

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2235949B1 (en) * 1973-06-18 1978-03-17 Roussel Uclaf
NZ214998A (en) * 1985-02-07 1989-06-28 Schering Ag 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions
DE3621024C2 (en) * 1986-06-20 1999-10-28 Schering Ag 11beta-phenylestradienes, their preparation and pharmaceutical preparations containing them
FR2620707B1 (en) * 1987-09-18 1989-12-08 Roussel Uclaf NOVEL STEROIDS COMPRISING A 3, 4 OR 6-CHAIN SPIRANIC CYCLE IN POSITION 17, THEIR PROCESS AND PREPARATION INTERMEDIATES, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2643638B1 (en) * 1989-02-24 1991-06-14 Roussel Uclaf NOVEL 19-NOR STEROIDS HAVING IN THE 11BETA POSITION A CARBON CHAIN COMPRISING AN AMIDE OR CARBAMATE FUNCTION, THEIR PREPARATION METHOD AND INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
HUT59416A (en) 1992-05-28
ATE162797T1 (en) 1998-02-15
HU912690D0 (en) 1992-01-28
CA2049102A1 (en) 1992-02-15
DE69128820D1 (en) 1998-03-05
AU8242291A (en) 1992-02-20
EP0471612A2 (en) 1992-02-19
DK0471612T3 (en) 1999-02-22
PT98681B (en) 1999-01-29
KR920004408A (en) 1992-03-27
EP0471612B1 (en) 1998-01-28
ES2112268T3 (en) 1998-04-01
MX9100647A (en) 1992-04-01
AU644671B2 (en) 1993-12-16
JPH06340688A (en) 1994-12-13
JP3073803B2 (en) 2000-08-07
GR3026315T3 (en) 1998-06-30
PT98681A (en) 1992-07-31
IE912863A1 (en) 1992-02-26
DE69128820T2 (en) 1998-06-10
EP0471612A3 (en) 1992-05-13

Similar Documents

Publication Publication Date Title
DE69214755D1 (en) Thiazolidine-2,4-dione derivatives, processes for their preparation and pharmaceutical compositions containing them
ES2190469T3 (en) ISOCUMARINE DERIVATIVES AND ITS USE IN PHARMACOS.
ZA916420B (en) 19-nor steroids having a carbonated chain containing an amide function in position 11 beta,their preparation,their use as medicaments and the pharmaceutical compositions containing them
DE69131813D1 (en) Amido-3-pyrazole derivatives, processes for their preparation and pharmaceutical compositions containing them
DE59103595D1 (en) NEW PHOSPHOLIPID DERIVATIVES OF NUCLEOSIDES, THEIR PRODUCTION AND THEIR USE AS ANTIVIRAL MEDICINAL PRODUCTS.
ATE248582T1 (en) SURFACTANT-FREE AEROSOL FORMULATIONS CONTAINING BECLOMETHASONE DIPROPIONATE
ATE104271T1 (en) 2-(2-HYDROXY-3PHENOXYPROPYLAMINO)ETHYLPHENOXYACETAMIDES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION.
DE69306212D1 (en) Cardioactive 17-aryl and 17-heterozyklyl-14 beta-5alpha-androstanes, androstenes and androstadienes, a process for their preparation and pharmaceutical preparations thereof
EP0219076A3 (en) Sustained release composition
DK509088D0 (en) 17-SPIRO STEROIDS, THEIR PREPARATION AND THE MEDICINAL PRODUCTS, CONTAINING THEREOF
ATE66224T1 (en) THIAZOLE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE19975037I2 (en) 3H-Imidazo-5,1-d-1,2,3,5-tetrazin-4-one derivatives Process for their preparation and pharmaceutical compositions containing them
DE69209442D1 (en) Dipeptide derivatives and prophylactic and therapeutic agents for bone diseases containing them
AU5007290A (en) New 19-nor steroids having in position 11beta a carbonated chain containing an amide or carbamate function, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them
DK163181C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF N, N&#39;-DI (ARYLALKYLENE) ALKYLENDIAMIN OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
ATE150466T1 (en) NEW 19-NOR STEROIDS WITH AN 11-BETA-PHENOXYSULFONAMIDE OR 11-BETA-PHENOXYSULFONYLUREA GROUP, METHODS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF, AND MEDICATIONS AND PHARMACEUTICAL PREPARATIONS THEREOF
IL72067A (en) 1-alkyl-androsta-1,4-diene-3,17-diones,processes for their preparation and pharmaceutical compositions containing the same
DE69707351D1 (en) New 1- or 6-hydroxylated steroids, a process for their preparation, their use as medicines and pharmaceutical preparations thereof
ATE138385T1 (en) NEW STEROIDS HAVING A METHYLENE-LACTONE GROUP CONDENSED AT THE 17TH PLACE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF, THEIR USE AS MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS THEREOF
DE69016627D1 (en) Novel steroid derivatives bearing a substituted ethyl radical at position 10 of the steroid, processes for their preparation, use as medicaments, one of these compounds and pharmaceutical preparations of this compound.
IL92268A0 (en) 14alpha,17alpha,ethanoestratriene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE59003718D1 (en) NEW AMIDINE GROUP-CONTAINING DIPHOSPHONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.
ATA234589A (en) NEW 2-METHOXYCARBONYL SUBSTITUTED N, N&#39;-DI (TRIMETHOXYBENZOYL) PIPERAZINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR CONTAINING THERAPEUTIC COMPOSITIONS
EP0271447A3 (en) Preventive measures for preventing the &#34;bovine complex respiratory disease&#34; by administering interferon
ATE145647T1 (en) GEM-DIPHOSPHONIC ACID-NITROSOCARBAMOYL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM